GIGYF1 and non-small cell lung carcinoma: Moreover, there are no relevant reports describing the antitumor effects of other miRNAs regulating GIGYF1 dysregulation, and we are the first to report miR-4731-5p-mediated modulation of GIGYF1 activity, especially in the context of NSCLC drug resistance.